Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “No Evidence of Disease Status”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableActive Not RecruitingNCT07235644
What this trial is testing

Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
MS (Multiple Sclerosis)Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (Relapsing Remitting)
Uppsala University 184
Not applicableEnded earlyNCT01561989
What this trial is testing

Cholecalciferol and Flu Vaccine in Treating Healthy Participants

Who this might be right for
Healthy, no Evidence of Disease
Roswell Park Cancer Institute 11
Not applicableUnknownNCT05635630
What this trial is testing

Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention

Who this might be right for
Metastatic Colorectal CancerNo Evidence of Disease StatusctDNA Monitoring
Fudan University 110
Not applicableActive Not RecruitingNCT01441687
What this trial is testing

Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome

Who this might be right for
Conditions Influencing Health StatusHealthyProstate Cancer
City of Hope Medical Center 243
Not applicableStudy completedNCT03725449
What this trial is testing

Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma

Who this might be right for
Dysplastic NevusHealth Status UnknownMelanoma+1 more
Rutgers, The State University of New Jersey 116
Not applicableEnded earlyNCT01073436
What this trial is testing

Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

Who this might be right for
Chronic Myeloid Leukemia
University of Michigan Rogel Cancer Center 7